Ireland

HAON Life Sciences secures €10.7M Grant to advance Cell Therapy for Infant Brain Injuries
Irish biotech startup HAON Life Sciences has been awarded a €10.7 million non-dilutive grant from Ireland’s Disruptive Technology Innovation Fund (DTIF) to accelerate development of a pioneering cell therapy for treating infant brain injuries.

The best Articles in our Network